Literature DB >> 1882850

Tumors of the urinary bladder in painters: a case-control study.

Z W Myslak1, H M Bolt, W Brockmann.   

Abstract

In a case-control study, 403 male patients with a diagnosis of "bladder tumor" and (as controls) 426 patients suffering from prostate disease were investigated. The results of this study indicate that past employment as a painter was associated with an excess risk of bladder tumor. The relative risk of bladder tumor estimated for painters was 2.76. The possible role of benzidine-based azodyes (or azodyes based on substituted benzidines) as a carcinogenic risk factor for painters is discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1882850     DOI: 10.1002/ajim.4700190604

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  5 in total

1.  [The causes of urinary bladder cancer and possibilities of prevention].

Authors:  K Golka; A W Rettenmeier; P J Goebell
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

2.  Bladder cancer and occupation: a case-control study in northern Italy.

Authors:  S Porru; V Aulenti; F Donato; P Boffetta; R Fazioli; S Cosciani Cunico; L Alessio
Journal:  Occup Environ Med       Date:  1996-01       Impact factor: 4.402

Review 3.  Occupational exposure and urological cancer.

Authors:  Klaus Golka; Andreas Wiese; Giorgio Assennato; Hermann M Bolt
Journal:  World J Urol       Date:  2003-11-26       Impact factor: 4.226

4.  [Confounding of occupational cancer risk in epidemiological studies due to ignorance of smoking data as exemplified by bladder and lung cancer in painters].

Authors:  H Scherg
Journal:  Soz Praventivmed       Date:  1995

5.  Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.

Authors:  Holger Schwender; Silvia Selinski; Meinolf Blaszkewicz; Rosemarie Marchan; Katja Ickstadt; Klaus Golka; Jan G Hengstler
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.